Antimicrobial resistance trends in fecal Salmonella isolates from northern California dairy cattle admitted to a veterinary teaching hospital, 2002-2016. by Davidson, Kelly E et al.
UC Davis
UC Davis Previously Published Works
Title
Antimicrobial resistance trends in fecal Salmonella isolates from northern California dairy 
cattle admitted to a veterinary teaching hospital, 2002-2016.
Permalink
https://escholarship.org/uc/item/8121q1nt
Journal
PloS one, 13(6)
ISSN
1932-6203
Authors
Davidson, Kelly E
Byrne, Barbara A
Pires, Alda FA
et al.
Publication Date
2018
DOI
10.1371/journal.pone.0199928
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
RESEARCH ARTICLE
Antimicrobial resistance trends in fecal
Salmonella isolates from northern California
dairy cattle admitted to a veterinary teaching
hospital, 2002-2016
Kelly E. Davidson1☯, Barbara A. Byrne2☯, Alda F. A. Pires1‡, K. Gary Magdesian3‡, Richard
V. Pereira1☯¤*
1 Department of Population Health and Reproduction, School of Veterinary Medicine, University of California,
Davis, United States of America, 2 Department of Pathology, Microbiology & Immunology, School of
Veterinary Medicine, University of California, Davis, United States of America, 3 Department of Medicine &
Epidemiology, School of Veterinary Medicine, University of California, Davis, United States of America
☯ These authors contributed equally to this work.
¤ Current address: University of California Davis One Shield, Davis, California, United States of America
‡ These authors also contributed equally to this work.
* rvpereira@ucdavis.edu
Abstract
Nontyphoidal Salmonella infections contribute to approximately 1.2 million annual illnesses
in the United States. Historical and recent outbreaks have been associated with dairy prod-
ucts, ground beef, and direct contact with cattle. Salmonella antimicrobial resistance (AMR)
is a serious concern that can reduce successful treatment of infections, increasing recovery
time, medical costs, and mortality rates in humans and animals. This highlights the need to
track AMR in Salmonella isolated from cattle to improve treatment plans, manage trends
in AMR, and prevent future AMR development. A total of 242 Salmonella isolates were
retrieved from 9,162 cattle fecal samples submitted to the University of California, Davis Vet-
erinary Medical Teaching Hospital from 2002 to 2016. These isolates were tested for antimi-
crobial susceptibility using a standardized broth dilution panel. Multidrug resistance (MDR)
to three or more classes of antimicrobials was observed in 50.8% of isolates, and the most
common MDR pattern was amoxicillin-ampicillin-cefoxitin-ceftiofur-ceftriaxone-chloram-
phenicol-streptomycin-tetracycline (23.2%). There were significantly greater odds for antimi-
crobial resistance to aminoglycosides (OR: 2.03, 95% CI: 1.1–3.7), penicillins (OR: 1.87,
95% CI: 1.007–3.5), and tetracyclines (OR: 1.87, 95% CI: 1.017–3.4) for the 2002–2009
period when compared to the 2010–2016 period. The most prevalent MDR serotypes were
Newport (100% MDR, n = 52), Typhimurium (100%, n = 20), and Dublin (71% MDR, n = 46).
Risk factors associated with higher odds for isolating MDR Salmonella included isolates from
calves when compared to adult cattle (OR: 22.0; 95% C.I.: 3.9–125.7), and isolates obtained
from cattle suspect of having salmonellosis versus from the infectious disease control sur-
veillance program (OR:13.7; 95%C.I.: 2.8–66.8). Despite a temporal trend for reduced AMR
to most antimicrobial drug classes, a lack of this observed in the 2002–2009 period when
compared to the 2010–2016 period for important drug classes such as cephalosporins (OR:
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1.6, 95% CI: 0.87–3.1), and a trend for temporal increase in resistant to quinolones drugs
(P value 0.004) highlight the relevance of AMR surveillance in cattle with Salmonella infec-
tions with the aim of targeting future prophylactic interventions.
Introduction
Nontyphoidal Salmonella is categorized by the Centers for Disease Control and Prevention
(CDC) as one of the top eighteen drug-resistant threats in the United States, associated with an
estimated 1.2 million infections, 100,000 antimicrobial-resistant infections, and 300 million
dollars in medical costs annually [1]. Though nontyphoidal Salmonella infections are rarely
life-threatening in healthy individuals, the presence of antimicrobial resistance (AMR) in this
organism can complicate and impede patient recovery and imposes an even greater risk for
at high risk populations (e.g. immunocompromised, children and elderly) [2]. Humans can
become diseased with nontyphoidal Salmonella via direct or indirect contact with infected live-
stock, which are in most cases asymptomatic. Some examples of disease transmission include:
direct contact with an infected animal, consumption of produce contaminated by manure
from infected animals, or consumption of beef, chicken, or other animal products derived
from infected animal [3].
Specifically, dairy cattle and dairy products have been demonstrated to be potential reser-
voirs for nontyphoidal Salmonella including serotypes known to display AMR and cause
foodborne illness in humans, such as Salmonella serotypes Newport and Typhimurium [4].
A recent, 2015–2016 outbreak affecting 36 people in ten states was linked to Salmonella
serotype Heidelberg in dairy calves, and isolates of these organisms were found to be multi-
drug resistant (MDR) [5]. Recent Salmonella outbreaks and observed resistance to medi-
cally-important drugs such as cephalosporins [6], highlight the continuing need for spatio-
temporal quantification of AMR in non-typhoidal Salmonella in dairy cattle. This will
facilitate estimating areas with higher risk for outbreaks caused by drug-resistant strains,
facilitating prevention and management to reduce the spread and dissemination of AMR
Salmonella.
Judicious use of antimicrobials is increasingly emphasized in the scientific and medical
communities with major efforts directed toward reducing and refining use of drugs in live-
stock production, as this constitutes a large portion of overall antimicrobial use [7]. Recently,
policymakers demonstrated high prioritization of antimicrobial stewardship in the livestock
industry through the Veterinary Feed Directive (VFD) effective in 2015 [8] as well as the Cali-
fornia Senate Bill 27 (SB27), which will come into effect in January 2018 [9]. The aim of the
SB27 is to improve veterinary oversight of antimicrobial drugs in livestock and promote col-
laboration between veterinarians, producers, research scientists, and the government to better
utilization of medically-relevant antimicrobials, increasing research on AMR bacteria and
improving drug use in livestock management. To better understand spread and dissemination
of antimicrobial resistance, this study aims to describe antimicrobial resistance trends in Sal-
monella isolated from dairy cattle in northern California.
The objective of this study was to identify trends in AMR of Salmonella isolates obtained
from cattle fecal samples isolated and tested in the University of California, Davis William R.
Pritchard Veterinary Medical Teaching Hospital (VMTH) microbiology laboratory between
January 1, 2002 and December 31, 2016. These data provide initial findings on antimicrobial
resistance of Salmonella overtime for area veterinarians and stakeholders and supporting
Antimicrobial resistance in California dairy cattle Salmonella
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information to manage antimicrobial use and more finely target research efforts to improve
animal health and food safety.
Material and methods
Study design
All Salmonella isolates obtained from dairy cattle fecal samples submitted to the University of
California, Davis William R. Pritchard Veterinary Medical Teaching Hospital (VMTH) micro-
biology laboratory between January 1, 2002 and December 31, 2016 were selected for antimi-
crobial susceptibility testing, totaling 242 isolates. During this period a total of 9,162 fecal
samples from cattle had been submitted for Salmonella culture, rendering a prevalence of
2.64% for Salmonella culture positive. Some of the isolates were recovered from dairy cattle
exhibiting clinical signs of salmonellosis, and the remaining isolates were recovered through
the VMTH Infectious Disease Control (IDC) program from asymptomatic dairy cattle. Rele-
vant variables such as year and month of sample collection, location (county) of farm of origin,
reason for sample collection, rough age group of each animal sampled, sex of animal, serotype,
serogroup, and results of any former antimicrobial susceptibility tests were retrieved from the
veterinary hospital records database for each Salmonella isolate, assuring client confidentiality.
Microbiologic procedure for Salmonella detection
Salmonella were isolated from submitted fecal samples using standardized bacteriologic cul-
ture methods, including selective enrichment in selenite broth (Vet Med Biological Media Ser-
vices, Davis, CA) overnight with subculture of selenite broth to xylose lysine tergitol 4 (Hardy
Diagnostics, Santa Maria, CA) and Hektoen enteric (Hardy Diagnostics) agars[10]. As a stan-
dard, approximately 10 grams or 10 ml of liquid feces were used for the enrichment in 100 ml
selenite broth. Less commonly, when minimal sample was submitted to the laboratory (e.g.
rectal swabs), approximately 0.5–1 grams of feces were used to inoculate 10 ml of selenite
broth. Confirmation of suspect colonies was performed using biochemical testing and/or
matrix-assisted laser desorption-ionization mass spectrometry (MALDI-TOF; Bruker Dal-
tonics, Fremont, CA). Confirmed Salmonella isolates were sent to the National Veterinary Ser-
vices Laboratories in Ames, Iowa for serotyping using standard protocols. Isolates were frozen
as stabilates at -80˚C until susceptibility testing and were revived on 5% sheep blood agar
(Hardy Diagnostics, Santa Maria, CA) incubated in 5% CO2 at 35˚C. Isolates were not pas-
saged further before antimicrobial susceptibility testing. Throughout the study period, every
tenth isolate tested for antimicrobial susceptibility was also re-confirmed as Salmonella using
MALDI-TOF.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was conducted using a microbroth dilution (MBD)
method per Clinical Laboratory Standards Institute (CLSI) guidelines [11]. All isolates were
tested against a standardized National Antimicrobial Resistance Monitoring System (NARMS)
panel (Thermo Fisher, Sensititre) for aerobic Gram negative bacteria that included penicillins
(ampicillin), beta-lactam/beta-lactamase inhibitor combinations (amoxicillin/clavulanic acid),
cephalosporins (ceftriaxone, ceftiofur, and cefoxitin), quinolones (ciprofloxacin and nalidixic
acid), phenicols (chloramphenicol), sulfas (sulfisoxazole and sulfamethoxazole/trimethoprim),
tetracyclines (tetracycline), macrolides (azithromycin), and aminoglycosides (gentamicin, and
streptomycin) [12]. Some isolates had already been tested for antimicrobial susceptibility to
some of these agents, but all isolates were retested against this standard panel of 14 antibiotics
Antimicrobial resistance in California dairy cattle Salmonella
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to assure consistency and improve surveillance of AMR. Positive and negative controls on
every MBD plate provided quality assurance. The Sensititre (Trek Diagnostic Systems, Oak-
wood Village, OH, USA) gram negative NARMS plate (CMV3AGNF) was used for testing iso-
lates. Plates were read using the Sensititre Vizion System1 (Thermo Fisher) and minimum
inhibitory concentrations (MIC) were interpreted using NARMS breakpoints [13]. Weekly
quality control was conducted using five strains of bacteria: Escherichia coli 25922, Escherichia
coli 35218, Enterococcus faecalis 29212, Staphylococcus aureus 29213, and Pseudomonas aerugi-
nosa 27853. All MIC results for these strains were interpreted using ranges recommended by
CLSI for quality control [11].
Data analysis
The statistical software programs Excel (Microsoft Corp., Redmond, WA), JMP and SAS (SAS
Institute Inc., Cary, NC) were used to process data for the Salmonella isolates and analyze the
serotype and AMR patterns of isolates for associations with relevant variables.
Using the FREQ function in SAS, the Cochran-Armitage trend test was used to evaluate
temporal trends in the prevalence of Salmonella resistant to drug being tested for isolates
obtained from 2002 to 2016. Cochran-Armitage Trend test was also used to evaluate shifts in
serotype distribution for the top 7 serovars (each representing at least 4% or more of the total
Salmonella isolates in the study), as well as one group containing all the remaining serotypes.
Serovar in the “others” group represent individual serotypes representing 2% or less of the
all Salmonella isolates used in the study. This was done because serotype was considered an
important potential confounding variable. Furthermore, temporal trends in the prevalence to
individual antimicrobial drugs tested to evaluate the role of serotype on antimicrobial resis-
tance trends. This was conducted using the LOGISTIC function in SAS, where the dependent
variable was the binary variable determining resistance or not to an antimicrobial, and the
independent variables were the top six serotypes, year interval (2002–2009 vs 2010–2016)
when isolate was collected, and the interaction of these two variables.
Multiple logistic regression models using GLIMMIX function in SAS were used to evaluate
the effect of sex, age, serotype and gender on the probability of Salmonella being resistant to
each antimicrobial drug tested, as well as multidrug resistant (MDR). MDR was defined as
resistance to at least one agent in three or more antimicrobial categories [14]. In these logistic
regression models, the binary dependent variable determined if isolates were or not MDR.
Year interval (2002–2009 vs 2010–2016) when isolates were collected was included in all mod-
els as an independent variable to evaluate temporal changes on antimicrobial resistance. These
two year periods were selected to compare the two halves of time period evaluated, as well as
due to legislation related to antimicrobial use that occurred after 2009, such as change on how
ceftiofur could be used in an extra-label matter in livestock [15]. A cluster was created within
serotype with serotypes for which less than 10 isolates were available. For all models, a P-value
of< 0.05 was considered to be a significant difference.
A heat map was generated using in JMP to display the distribution of Salmonella nonsus-
ceptible to ceftriaxone by serotype. Isolates were labeled as nonsusceptibility to ceftriaxone if
classified as either intermediate or resistant to ceftriaxone.
Results
Antimicrobial susceptibility profiles
Cochran-Armitage trend test revealed a significant trend for reduction in the annual preva-
lence of antimicrobial resistance for Salmonella obtained from 2002–2016 for amoxicillin (P
value 0.001), ampicillin (P value<0.001), cefoxitin (P value 0.001), ceftiofur (P value 0.001),
Antimicrobial resistance in California dairy cattle Salmonella
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ceftriaxone (P value 0.001), chloramphenicol (P value 0.001), gentamicin (P value<0.001),
streptomycin (P value<0.001), tetracycline (P value<0.001), and trimethoprim/ sulfamethox-
azole (P value 0.002)(Figs 1 to 4). The only antimicrobial with an increasing trend in the
annual prevalence of antimicrobial resistance for Salmonella from 2002–2016 was the quino-
lone drug nalidixic acid (P value 0.004). Azithromycin, sulfisoxazole and ciprofloxacin were
not included in this analysis because no isolates in this study was resistant to these drugs.
Aminoglycosides (gentamicin, streptomycin; Fig 1)(OR: 2.03, 95% CI: 1.1–3.7, P value
0.02), penicillins (ampicillin; Fig 2)(OR: 1.87, 95% CI: 1.007–3.5, P value 0.04), and tetracycline
(Fig 4)(OR: 1.87, 95% CI: 1.017–3.4, P value 0.04) showed significantly greater odds for antimi-
crobial resistance in the 2002–2009 period when compared to the 2010–2016 period. No sig-
nificant difference in the odds for resistance to cephalosporins (OR: 1.6, 95% CI: 0.87–3.1, P
value 0.12), folate pathway inhibitors (trimethoprim/ sulfamethoxazole; Fig 3)(OR: 1.18, 95%
CI: 0.50–2.76, P value 0.69), beta-lactam/beta-lactamase inhibitor combinations (amoxicillin/
clavulanic acid; Fig 2)(OR: 1.79, 95% CI: 0.94–3.4, P value 0.07), and phenicols (OR: 1.6, 95%
CI: 0.87–3.1, P value 0.12) was observed when the 2002–2009 period was compared to the
2010–2016 period (Figs 1 to 4).
Minimum inhibitory concentration distribution for Salmonella for each antimicrobial
tested is displayed in Table 1. Decreased susceptibility to ciprofloxacin (DSC), defined as iso-
lates with an MIC > = 0.12 μg/ml, is used as a marker for emerging fluoroquinolone resistance
[16]. Although no isolate was classified as resistant to ciprofloxacin, two percent of isolates fell
within the DSC category (Table 1). These were the same two isolates classified as resistant to
nalidixic acid.
Of the nine antimicrobial classes represented on the standardized NARMS panel of drugs,
all isolates were susceptible to azithromycin (macrolide), with two isolates nonsusceptible to
ciprofloxacin. Resistance to the quinolone nalidixic acid was observed in 0.8% (2/242) of
Fig 1. Prevalence of antimicrobial resistance to gentamicin and streptomycin antimicrobials exhibits a decreasing
linear trend from 2002–2016. There are significantly higher odds for resistance to aminoglycosides for the 2002–2009
period when compared to the 2010–2016 period (OR: 2.03, 95% CI: 1.1–3.7).
https://doi.org/10.1371/journal.pone.0199928.g001
Antimicrobial resistance in California dairy cattle Salmonella
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Salmonella isolates. These two isolates were classified as resistant to nalidixic acid and included
in both the nonsusceptibility prevalence graph as well as the MDR analyses (Fig 2; Table 2).
Resistance to ceftriaxone was observed in 40.1% (97/242) of Salmonella isolates and was
observed in 22.5% (9/40) of the serotypes identified throughout the study period. At least two
Salmonella isolates per year from 2002–2015 were resistant to ceftriaxone, with susceptibility
to ceftriaxone observed among the six Salmonella isolates obtained from dairy cattle fecal sam-
ples in 2016 (Fig 5). Only serotypes with at least one isolate nonsusceptible to ceftriaxone were
included in Fig 5 (n = 151). Because antimicrobial susceptibility testing to ceftiofur and ceftri-
axone was the same for all isolate, Fig 5 can also be interpreted as serotypes with at least one
isolate nonsusceptible to ceftiofur.
Serotypes
Cochran-Armitage trend test revealed a significant trend for decreased annual prevalence of
serotypes Dublin (P value 0.006) and Newport (P value 0.005) from 2002–2016. A significant
trend for increase was observed for Montevideo (P value<0.001), Mbandaka (P value
0.044) and others (P value<0.001). No significant change towards increasing or decreasing
Fig 2. Prevalence of antimicrobial resistance to nalidixic acid has an increasing trend from 2002–2016, and antimicrobial resistance to
beta-lactam antimicrobials and a beta-lactam/beta-lactamase inhibitor combination exhibit decreasing linear trends from 2002–2016.
There are significantly higher odds for resistance to amoxicillin/clavulanic acid (OR: 1.79, 95% CI: 0.94–3.4) and ampicillin (OR: 1.87, 95% CI:
1.007–3.5) for the 2002–2009 period when compared to the 2010–2016 period. There was no significant difference in odds for resistance to
cephalosporins for the 2002–2009 period when compared to the 2010–2016 period (OR: 1.6, 95% CI: 0.87–3.1). Resistance to nalidixic acid
occured only in the 2010–2016 period.
https://doi.org/10.1371/journal.pone.0199928.g002
Antimicrobial resistance in California dairy cattle Salmonella
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Fig 3. Prevalence of antimicrobial resistance to folate pathway inhibitors exhibits a decreasing linear trend from 2002–2016. However,
no significantly higher odds for resistance to folate pathway inhibitors for the 2002–2009 period when compared to the 2010–2016 period
(OR: 1.18, 95% CI: 0.50–2.76).
https://doi.org/10.1371/journal.pone.0199928.g003
Fig 4. Prevalence of antimicrobial resistance to tetracycline and chloramphenicol exhibit decreasing linear trends from 2002–2016.
There are significantly higher odds for resistance to tetracycline for the 2002–2009 period when compared to the 2010–2016 period (OR: 1.87,
95% CI: 1.017–3.4). No significant difference in odds for resistance to phenicols for the 2002–2009 period when compared to the 2010–2016
period (OR: 1.6, 95% CI: 0.87–3.1).
https://doi.org/10.1371/journal.pone.0199928.g004
Antimicrobial resistance in California dairy cattle Salmonella
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prevalence was observed for Typhimurium (P value<0.10), Muenster (P value 0.5) and Melea-
gridis (P value 0.038)(Fig 6).
For all antimicrobial tested in the study, prevalence of resistance for the top six serovars was
not significantly different for the 2002–2009 period when compared to the 2010–2016 period.
Table 2. Distribution of pansusceptible and resistant patterns of 242 Salmonella isolates to the NARMS gram-negative antimicrobial panel.
Susceptibility Pattern Count Prevalence
Pansusceptible 112 46.3%
AuAmFoxXnlCroChoStrTe 38 15.7%
AuAmFoxXnlCroChoStrTeSxt 17 7.0%
AuAmFoxXnlCroChoGmStrTe 16 6.6%
AuAFoxXnlCroStrTeSxt 10 4.1%
AmStrTe 8 3.3%
ChoStrTe 8 3.3%
AuAmFoxXnlCroChoGmStrTeSxt 7 2.9%
Str 7 2.9%
AmChoStrTe 6 2.5%
AuAmFoxXnlCroChoGmTe 6 2.5%
AmChoGmStrTeSxt 2 0.8%
AuAmFoxXnlCroChoNaStrTe 1 0.4%
AuAmFoxXnlCroChoNaStrTeT/S 1 0.4%
AuAmFoxXnlCroStr 1 0.4%
ChoGmStrTe 1 0.4%
FoxChoGmStrTeSxt 1 0.4%
Au, amoxicillin/clavulanic acid; Am, ampicillin; Fox, cefoxitin; Xnl, ceftiofur; Cro, ceftriaxone; Cho, chloramphenicol; Gm, gentamicin; Na, nalidixic acid; Str,
streptomycin; Te, tetracycline; Sxt, trimethoprim/sulfimethoxazole
https://doi.org/10.1371/journal.pone.0199928.t002
Table 1. Percent distribution of MIC resistant for Salmonella isolates (n = 242) for isolates. Highlighted areas in blue correspond to susceptible, in yellow correspond
to intermediate, and in red highlighted area correspond to resistant.
% Distribution of MICs (μg/ml)
Antimicrobial 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128 256
AU 50 3 2 4 40
AM 45 8 1 46
AZO 75 24 1
FOX 21 25 13 40
XNL 1 3 52 2 1 40
CRO 58 2 2 16 16 5
CHO 18 38 1 43
CIP 46 50 2 1 1
GM 16 58 10 2 1 13
NA 1 15 78 6 1
STR 6 31 11 10 41
FIS 1 1 2 13 83
TE 50 50
SXT 49 19 13 2 1 16
AU, amoxicillin/clavulanic acid; AM, ampicillin; AZO, azithromycin; FOX, cefoxitin; XNL, ceftiofur; CRO, ceftriaxone; CHO, chloramphenicol; CIP, ciprofloxacin;
GM, gentamicin; NA, nalidixic acid; STR, streptomycin; FIS, sulfisoxazole; TE, tetracycline; SXT, trimethoprim/sulfamethoxazole.
https://doi.org/10.1371/journal.pone.0199928.t001
Antimicrobial resistance in California dairy cattle Salmonella
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Multi-drug resistance and serotypes
Multi-drug resistance was observed in 50.8% (123/242) of Salmonella isolates (Fig 7). The most
common MDR pattern was amoxicillin/clavulanic acid—ampicillin—cefoxitin—ceftiofur—
ceftriaxone—chloramphenicol—streptomycin—tetracycline (Au-Am-Fox-Xnl-Cro-Cho-Str-
Te; 15.7%), and the second and third most common MDR patterns were similar, with the addi-
tion of trimethoprim-sulfamethoxazole (Sxt; 7.0%) and gentamicin (Gm; 6.6%) to this base
pattern, respectively (Table 2). Approximately 46% of isolates were pansusceptible. Of the
40 unique Salmonella serotypes observed over the study period, the most common were
Newport (21.5%), Dublin (19.0%), and Typhimurium (9.1%) (Table 3). A significantly higher
(P value < 0.0001) prevalence of S. Dublin was observed in isolates from calves (43%) when
compared to isolates from adult animals (10%).
Fig 5. Salmonella serotypes Dublin, Newport, and Typhimurium display nonsusceptibility to ceftriaxone in multiple years of the study
period. Only serotypes with at least one isolate nonsusceptible to ceftriaxone were included in the analysis (n = 151). The heatmap legend
represents the prevalence of ceftriaxone resistant Salmonella.
https://doi.org/10.1371/journal.pone.0199928.g005
Antimicrobial resistance in California dairy cattle Salmonella
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Fig 6. Annual prevalence of Salmonella by the top 7 serotypes. “Others” represents the clustering of all other serotypes not included in the top
seven.
https://doi.org/10.1371/journal.pone.0199928.g006
Fig 7. Prevalence of Salmonella culture positive and multidrug resistant (MDR) Salmonella isolates from fecal samples
submitted between 2002 and 2016.
https://doi.org/10.1371/journal.pone.0199928.g007
Antimicrobial resistance in California dairy cattle Salmonella
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Table 3. Distribution of serotypes and percent of multidrug resistance isolates observed among 242 Salmonella isolates by time frame.
Serotype 2002 to 2009 (n = 185) 2010 to 2016 (n = 57)
% (n) % MDR (n) % (n) % MDR (n)
S.NEWPORT 24% (45) 100% (45) 12% (7) 100% (7)
S.DUBLIN 22% (40) 85% (33) 11% (6) 100% (6)
S.TYPHIMURIUM 8% (15) 100% (15) 9% (5) 100% (5)
S.MELEAGRIDIS 9% (16) 19% (3) 0% (0)
S.MUENSTER 9% (16) 0% (0)
S.MBANDAKA 4% (8) 14% (8)
S.MONTEVIDEO 2% (4) 25% (1) 11% (6)
S.UGANDA 1% (2) 5% (3)
S. SP. 4,12:i:- 0% (0) 4% (2)
S.BERTA 0% (0) 4% (2)
S.IDIKAN 0% (0) 4% (2)
S.BARRANQUILLA 2% (3) 2% (1)
S. SP. 4,5,12:i:- 1% (2) 2% (1) 50% (1)
S.TENNESSEE 1% (2) 2% (1)
S.ORANIENBURG 1% (2) 2% (1)
S.SAINTPAUL 1% (2) 2% (1)
S. rough O:GMS:- 0% (0) 2% (1)
S. sp. (3,12:l,z13:-) 0% (0) 2% (1)
S. sp. (4,5,12:I:) 0% (0) 2% (1)
S. sp. (9,12:NONMOTILE) 0% (0) 2% (1) 100% (1)
S.ARIZONAE 0% (0) 2% (1)
S.BRAENDERUP 0% (0) 2% (1)
S.DERBY 0% (0) 2% (1)
S.ENTERIDITIS 0% (0) 2% (1)
S.GIVE 0% (0) 2% (1) 100% (1)
S.MUEC 0% (0) 2% (1)
S.THOMPSON 0% (0) 2% (1)
S.SENFTENBERG 3% (5) 0% (0)
S.ALTONA 2% (4) 0% (0)
S.ANATUM 2% (3) 0% (0)
S.HEIDELBERG 2% (3) 0% (0)
S. SP. 3,1:e,h:- 1% (2) 0% (0)
S.HAVANA 1% (2) 0% (0)
S.INFANTIS 1% (2) 100% (1) 0% (0)
S. SP. 3,12:NONMOTILE 1% (1) 0% (0)
S.AGONA 1% (1) 0% (0)
S.CERRO 1% (1) 0% (0)
S.LEXINGTON 1% (1) 0% (0)
S.MUENCHEN 1% (1) 0% (0)
S.POONA 1% (1) 0% (0)
S.READING 1% (1) 100% (1) 0% (0)
 Percent of isolates for that serotype classified as multidrug resistant.
https://doi.org/10.1371/journal.pone.0199928.t003
Antimicrobial resistance in California dairy cattle Salmonella
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Risk factors
Prevalence of multidrug resistance in Salmonella isolates significantly varied based on age
group of animal, serotype, and submission type of Salmonella isolates. There was a significantly
higher odds ratio of isolating MDR Salmonella from calves when compared to adult cattle
(P-value = 0.0004) and from disease suspects when compared to samples collected due to the
hospital IDC program (P-value = 0.001) (Table 4). Location (county) of farm of origin (P-
value = 0.79) and sex of animal (P-value = 0.63) were not significantly associated with a higher
prevalence of MDR Salmonella. Year group (2002–2009 vs 2010–2016) did not have a signifi-
cant effect on the odds ratio of isolating MDR Salmonella (P-value = 0.20). Salmonella serotype
had a significant effect on the prevalence of MDR isolated (P-value < 0.0001). If an isolate was
serotype Newport, Meleagridis, Typhimurium or Dublin a significantly higher probability for
MDR was observed when compared to a reference group composed of serotypes for which less
than 10 isolates were available. All other risk factors evaluated were not significantly associated
with a higher probability of isolating MDR Salmonella.
Discussion
Identifying trends in AMR in dairy cattle Salmonella isolates provides vital surveillance data to
the scientific and medical communities to guide research, judicious antimicrobial use, and
selection of effective treatment plans. The decreasing linear trends in antimicrobial resistance
prevalence observed for three antimicrobial classes from 2002–2016 support the notion that
susceptibility profiles of Salmonella isolated from northern California dairy cattle fecal samples
are changing over time (Figs 1–4). A study conducted in bovine Salmonella enterica submitted
to the Wisconsin Veterinary Diagnostic Laboratory from 2006–2015 observed similar findings,
Table 4. Evaluation of risk factors for prevalence of multidrug resistant (MDR) Salmonella from 2002 to 2016 (n = 242), based on age, sample submission type, sero-
type and year group isolated.
Factor % MDR Prevalence1(total count) OR (95% C.I.)2 P-value
Age Group 0.0001
Adult 39% (170) 22.0 (3.9–125.7)
Calves 82% (67) Reference
Submission Type 0.0004
Suspects 76% (107) 13.7 (2.8–66.8)
IDC 31% (135) Reference
Serotype <0.0001
Dublin 85% (46) 112.8 (11.8–1,072)
Mbandaka 0% (16) -
Meleagridis 19% (16) 11.8 (1.1–121.1)
Montevideo 10% (10) 0.14 (0.009–2.0) 
Muenster 0% (18) - 
Newport 100% (52) -
Typhimurium 100% (22) -
Other 10% (62) Reference
1 Prevalence of multidrug resistant Salmonella within each variable and number of isolates within each category.
2 Odds ratio for having Salmonella being MDR due to the factor being evaluated. The 95% confidence interval is in parentheses.
 Cluster of serotypes for which less than 10 isolates were available.
 Odds ratio not calculated because either all isolates in that category were multidrug resistant or all isolates in that category were not multidrug resistant.
 95% CI for the odds ratio included 1, indicating lack of evidence for isolated being MDR
https://doi.org/10.1371/journal.pone.0199928.t004
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with trend for decreasing antimicrobial resistance observed overtime for gentamicin, neomy-
cin, and trimethoprim sulfamethoxazole [17]. While a decreasing trend in resistance patterns
for most antimicrobial classes was observed, there is still a problem with antimicrobial resis-
tance for cephalosporins and quinolone drugs as evidenced by lack of significant difference
in odds for resistance to cephalosporins between the 2002–2009 and 2010–2016 periods and
identification of isolates resistance to quinolones in 2013 and 2015.
The fact that there was no significant difference in odds ratio for resistance to cephalospo-
rins for the 2002–2009 period when compared to the 2010–2016 period is worth noting
because cephalosporins are key drugs for treating human patients with severe nontyphoidal
Salmonella infections, especially ceftriaxone. While ciprofloxacin is commonly prescribed to
adults with salmonellosis, third-generation cephalosporins such as ceftriaxone are the pre-
ferred treatment for children [18]. The presence of nonsusceptibility to ceftriaxone in multiple
serotypes known to cause foodborne illness in humans such as S. Dublin, S. Newport and S.
Typhimurium show that continued surveillance of dairy cattle Salmonella isolates is warranted
(Fig 5)[19].
Approximately 50% of Salmonella isolates in our study were MDR, this is within the
expected prevalence for MDR in cattle, with a study on antimicrobial resistance among Salmo-
nella from dairy cattle in the Northeastern US from 2004–2011 reporting a prevalence of
MDR Salmonella of 46% [20]. When evaluating risk factors for prevalence of MDR Salmonella,
age group, and submission type played a significant role (Table 4). It was not unexpected to
observe that Salmonella from calves had a higher probability of being MDR when compared to
adult animals: this has been previously observed that calves have a higher proportion of MDR
enteric bacteria when compared to cows [21, 22]. One hypothesis is that undeveloped intesti-
nal microflora in young calves could influence higher colonization of younger calves by patho-
genic and antimicrobial resistant enteric bacteria. Resistance to colonization by bacteria with a
higher fitness cost, such as antimicrobial-resistant bacteria and pathogenic enteric bacteria,
may follow as the calves’ indigenous microflora matures and the enteric microbiota diversity
increases, resulting in a decreased prevalence of resistant bacteria [23, 24]. Additionally, a
significantly higher (P value < 0.0001) prevalence of S. Dublin was observed in calves (43%)
when compared to adult animals (10%), and due to the association of S. Dublin with being
MDR, the higher prevalence of infection of calves with this serotype likely affected the higher
probability of calves being isolated with MDR Salmonella.
In our study we also observed a higher prevalence of MDR Salmonella in animals that were
sampled based on being suspects for having clinical salmonellosis versus as part of the standard
veterinary hospital IDC protocol. A hypothesis for this finding may be that animals that are
suspect for salmonellosis may have higher odds for being recently treated with one or more
antimicrobials due to clinical signs associated with salmonellosis prior to arriving at the hospi-
tal or during hospitalization, and that selection pressure for antimicrobial resistance may have
occurred. This could occur either as a consequence of MDR Salmonella to survive exposure to
multiple antimicrobial treatments with difference drug classes, as well as the selective pressure
antimicrobial treatments exert on enteric microbiota, facilitating the dominance of a MDR iso-
late that otherwise would not been able to compete with commensal microbiota, facilitating
therefore the clonal dissemination of a MDR isolate [25]. One study observed that recent treat-
ment of adult cattle with antimicrobials significantly increased the risk of shedding Salmonella
group B (OR = 2.1; 95% CI: 1.4–3.0) [26]. Clinical signs of bovine salmonellosis may include
fever, diarrhea, anorexia, dehydration, decreased milk production, abortion, and endotoxemia,
although many infections remain subclinical [27]. In comparison to animals that may be at the
veterinary hospital for reasons unrelated to those expected for an animal with salmonellosis,
they may not have recently been exposed to the same antimicrobial selection pressures that
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would increase the odds for isolating multidrug resistant Salmonella. In agreement with our
hypothesis, a previous study observed that multidrug resistance was found to be highly preva-
lent among isolates from cattle with clinical signs of salmonellosis [28]. As an example, S.
Cerro is frequently isolated from cattle subclinical for salmonellosis, and S. Cerro isolates are
usually pansusceptible [29]. Animals shedding Salmonella subclinically highlight the impor-
tance of IDC protocols, which is of higher relevance in large animal veterinary hospitals which
have patients that may have a depressed immune system and may be more vulnerable to devel-
oping clinical salmonellosis after exposure [30].
Although no isolate was classified as resistant to ciprofloxacin, two percent of isolates fell
within the DSC category (Table 1). Quinolone antibiotics act by inhibiting the topoisomerase
enzymes, DNA gyrase and topoisomerase IV, which maintain the level of supercoiling in the
bacterial DNA[31]. Quinolone resistance can result from point mutations in housekeeping
genes (e.g., gyrA), rather than the presence of resistance genes, even though the presence of
some resistance genes (e.g., qnr gene) may confer low level resistance and could result in
reduced susceptibility without changing the classification of an isolate from susceptible to
intermediate or resistant [32, 33]. The identification of these DSC isolates in 2013 and 2015
highlights the importance of continued monitoring of potential increased selection of resis-
tance to fluoroquinolone drugs in livestock and evaluation of potential spread through direct
contact or the food chain.
The 2015 NARMS report outlined an increase in MDR prevalence of Salmonella isolated
from humans from ~9.5% from 2009–2014 to 12% in 2015 driven by a S. Typhimurium variant
named 4,[5],12:i:- [19]. In this study, four Salmonella isolates were serotype 4,[5],12:i:-, and
these were observed in 2009, 2010 (2), and 2014. Multidrug resistance was observed only in the
most recent (2014) of the four 4,[5],12:i:- isolates, with its susceptibility pattern nearly match-
ing the frequently observed AST pattern as outlined by the NARMS report (Table 2). Addi-
tionally, the NARMS report raised concerns about MDR in S. Dublin. Although this serotype
is host adapted to cattle, it is becoming more prevalent in humans and tends to cause severe
infection. The NARMS report also stated that MDR in Salmonella Dublin continues to
increase, being responsible for 11 out of 12 human Salmonella isolates and 28 out of 31 cattle
isolates being reported [34]. Of the 46 S. Dublin isolates analyzed in this study, 85% were
MDR, with 100% of S. Dublin isolates in the more recent 2010–2016 period displaying MDR
(Table 3). A recent study that conducted whole genome sequencing of Salmonella isolated
from humans and cattle between 2008 and 2012 from NY and WA, observed a close similarity
between S. Dublin resistance genes as well as plasmids between Salmonella isolated from
humans and cattle. This held true between different years, with geographical location having a
greater influence on the differences observed, resulting in the presence of aadB and cmlA, as
well as streptomycin resistance genes in isolates from WA but not NY [35]. This highlights
that cattle continue to be an important potential reservoir of S. Dublin to humans, and selec-
tion of antibiotic resistance in cattle could increase the risk of multidrug resistance among Sal-
monella isolates from humans.
The three most common serotypes observed in the 2002–2009 period of our study (S. New-
port, S. Dublin, and S. Typhimurium) were also frequently observed by the United States
Department of Agriculture’s Food Safety and Inspection Service (USDA-FSIS) among isolates
obtained from ground beef at slaughter houses. Specifically, S. Dublin was consistently among
the top three serotypes in ground beef reported annually by FSIS during 2007–2009 and is
among the top ten reported ground beef Salmonella serotypes since 2003 [36]. Salmonella is
known to be host-adapted in cattle, and it is therefore not unexpected to find it in ground beef
[37]. A trend for a lower prevalence of S. Dublin and S. Newport from 2002–2016 was observed
in our study. S. Montevideo was also observed less frequently during the 2002–2009 period in
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our study than in USDA-FSIS reports during the same time frame. S. Montevideo was the
most prevalent serotype reported annually by USDA-FSIS during 2002–2009, whereas only 2%
(4/185) of isolates in our study were S. Montevideo from 2002–2009. We also observed a trend
from higher prevalence of S. Montevideo from 2002–2016. The reason for this difference and
trend is not clear.
Of the four most common serotypes observed in the 2010–2016 period in our study (S.
Mbandaka, S. Newport, S. Dublin, and S. Montevideo), USDA-FSIS similarly reported high
prevalence of each except for S. Mbandaka throughout 2010–2016. Our study reported a
relatively high 14% (8/57) prevalence of S. Mbandaka in the 2010–2016 period, as well as an
increasing trend for prevalence of S. Mbandaka from 2002–2016. Based on USDA-FSIS data,
S. Mbandaka has historically been of low-to-variable importance as a foodborne pathogen in
ground beef, particularly in recent years. However, a study conducted with data on Salmonella
prevalence in commercial ground beef in the United States from 2005–2007 observed a high
prevalence of S. Mbandaka from ground beef [38]. Disparities observed between our findings
and NARMS or USDA-FSIS reports could be related to the fact that our samples were feces
rather than ground beef, and highlights the importance of recognizing the potential bias when
using data from NARMS or USDA-FSIS reports to predict prevalence of different serotypes at
the farm level. However, efforts have been initiated to evaluate the feasibility of conducting on-
farm sampling to monitor AMR [39].
Shift in dominance of specific serotypes has been considered a factor that could have
affected temporal changes in the prevalence of antimicrobial resistance Salmonella overtime.
As already mentioned, we observed trends for decreasing (Dublin and Newport) and increas-
ing (Montevideo and Mbandaka) prevalence from 2002–2016 for some of the top serotypes
observed in Salmonella from our study. However, no significant temporal shift in prevalence
of antimicrobial resistance to any of the drugs tested was found to be associated with temporal
changes in serotype prevalence in our study. One study monitoring bovine Salmonella isolates
from dairy cattle in the northeastern United States isolated from samples submitted to an ani-
mal health diagnostic center from 2004–2011, observed a significant increase in the trend for
prevalence of resistance to ceftifour (P value 0.002), as well as a decreasing trend in prevalence
of resistance to spectinomycin (P value 0.003) among S. Newport isolates [20]. In that study,
no trend for increase or decrease in antimicrobial resistance was observed for other serotypes.
This furthermore highlights the importance of evaluating temporal trends in antimicrobial
resistance that could be caused by shifts in prevalence of specific serotype.
Limitations of this study include sampling bias, as samples collected from animals admitted
to the Veterinary Medical Teaching Hospital could be influenced by health status of the animal
as well as perceived value of the animal to the owner. Therefore, data from our study does not
necessarily represent the prevalence of Salmonella or antimicrobial resistance patterns of the
cattle population in general in this region of California, but rather that of a large animal veteri-
nary teaching facility.
Conclusion
The odds of isolating multidrug resistant Salmonella from cattle in this veterinary hospital had
a decreasing trend over the two time periods studied. Despite reduced prevalence of resistance
to three drug classes in the 2010–2016 period as compared to the 2002–2009 period, a lack of
a significant reduction in resistance for important drug classes such as cephalosporins, and
quinolones highlight the relevance of continual AMR surveillance in cattle with Salmonella
infections in future interventions. A lower prevalence of MDR isolates was observed for the
IDC protocol sampling compared to sampling conducted in suspect clinical salmonellosis
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cases; however, this does not reduce the importance for IDC protocols to reduce the spread of
Salmonella in veterinary hospitals from subclinical shedders.
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